ECGs and vital signs were unremarkable and similar across all treatments. Plasma TCA concentration across the FX006 doses were linear and dose-dependent. Peak plasma concentrations achieved with 40 mg TCA IR were 10X of those seen with FX006 40 mg. Conclusions: It is demonstrated that sustained residency of TCA in the joint prolongs therapeutic effect. The 40 mg dose of FX006 produced an effect at Week 12 (À3.7) that was equivalent to the maximal effect of TCA IR at Week 4. Surprisingly, between Weeks 2 and 11, the analgesic effect of the 40 mg dose of FX006 exceeded the maximal effect of TCA IR seen at Week 4. This observation suggests that prolonged occupation of the corticosteroid receptor may be associated with an enhanced analgesic effect. Further, this amplification of effect may constitute a meaningful clinical improvement relative to TCA IR as indicated by the 20% responder analysis for the 40 mg dose of FX006. A study is underway to determine the TCA concentrations in the joint at varying time points, and subsequent studies against placebo will define effect size and duration of action. Purpose: Knee instability is common in persons with knee osteoarthritis (OA). Yet, little is known regarding risk factors for knee instability and therefore the etiology and appropriate therapeutic interventions for this problem are unclear. Perceived knee instability may have variations in severity from actual 'giving way' of the knee ("buckling") to sensations that a knee is slipping or shifting but may not actually give way ("slipping"). Knee instability has been found to be associated with muscle weakness, a treatable cause, in several studies but none have examined if weakness predicts onset or worsening of instability. In addition, it is unknown whether decreased vibratory sense, common in older adults, is present with knee OA, and may create alterations in knee position sense, increasing vulnerability to instability. Here, we evaluate the associations of muscle strength and vibratory sense with the incidence and worsening of knee instability. Methods: MOST is a NIH-funded longitudinal study of persons with or at risk for symptomatic knee OA. Participant visits at 60, 72 and 84 months were used for this analysis. At the 60-month visit, participants underwent evaluation of unilateral isokinetic knee extensor strength and bilateral evaluation of vibratory perception threshold (VPT). VPT was evaluated using a biothesiometer. The applicator tip was placed on preselected anatomic bony prominences. The voltage was initially set at "0" and then increased by 1 volt/second until the participant acknowledged sensation and this was defined as the VPT. The mean VPT between the limbs was used for analyses. Quadriceps strength was evaluated as the maximum torque during active isokinetic extension. Strength measures were corrected for gravity by dividing the maximum torque by BMI. VPT and quadriceps muscle strength were categorized into sex-specific groups based on AE1 SD of the mean of the sample. At all visits, participants were asked about symptoms and frequency of knee instability in the past 3 months. Knee "buckling" was defined according to a question that asked if and how many times the participant noted their knee "giving way". Knee "slipping" was defined according to a question that asked if and how many times the knee "felt like it was shifting, slipping, or going to give way but didn't actually do so". Knee instability was defined as the occurrence of either symptom. Incident instability was defined as someone who answered "no" to experiencing either symptom at the 60 month visit but answered "yes" to one or both at the 72 or 84 month visit. Worsening of instability was defined as an increase in frequency using the 3-level variable with 0-1 times, 2-5 times, and >5 episodes over 3 months. Subjects with >5 times instability at 60 M were excluded. An increase in one level or more of frequency was considered worsening. A person-based analyses using Poisson regression with robust error variance to estimate adjusted relative risk for the association of VPT and muscle strength with knee instability incidence and progression was performed. We adjusted in analyses for age, sex, BMI, race, clinic site, KL grade and WOMAC knee pain as well as for each predictor (muscle strength and VPT). 31 [6]). 17% of participants reported buckling, 29% reported slipping and 37% reported instability (buckling and/or slipping) in the past 3 months at the 60-month visit. Over the follow-up period, 32% developed incident instability, and 20% had incident buckling. Similarly, 11% had worsening of instability, and 21% had worsening of buckling. Quadriceps weakness and impaired Abstracts / Osteoarthritis and Cartilage 22 (2014) S57-S489 S377
Purpose: Knee instability is common in persons with knee osteoarthritis (OA). Yet, little is known regarding risk factors for knee instability and therefore the etiology and appropriate therapeutic interventions for this problem are unclear. Perceived knee instability may have variations in severity from actual 'giving way' of the knee ("buckling") to sensations that a knee is slipping or shifting but may not actually give way ("slipping"). Knee instability has been found to be associated with muscle weakness, a treatable cause, in several studies but none have examined if weakness predicts onset or worsening of instability. In addition, it is unknown whether decreased vibratory sense, common in older adults, is present with knee OA, and may create alterations in knee position sense, increasing vulnerability to instability. Here, we evaluate the associations of muscle strength and vibratory sense with the incidence and worsening of knee instability. Methods: MOST is a NIH-funded longitudinal study of persons with or at risk for symptomatic knee OA. Participant visits at 60, 72 and 84 months were used for this analysis. At the 60-month visit, participants underwent evaluation of unilateral isokinetic knee extensor strength and bilateral evaluation of vibratory perception threshold (VPT). VPT was evaluated using a biothesiometer. The applicator tip was placed on preselected anatomic bony prominences. The voltage was initially set at "0" and then increased by 1 volt/second until the participant acknowledged sensation and this was defined as the VPT. The mean VPT between the limbs was used for analyses. Quadriceps strength was evaluated as the maximum torque during active isokinetic extension. Strength measures were corrected for gravity by dividing the maximum torque by BMI. VPT and quadriceps muscle strength were categorized into sex-specific groups based on AE1 SD of the mean of the sample. At all visits, participants were asked about symptoms and frequency of knee instability in the past 3 months. Knee "buckling" was defined according to a question that asked if and how many times the participant noted their knee "giving way". Knee "slipping" was defined according to a question that asked if and how many times the knee "felt like it was shifting, slipping, or going to give way but didn't actually do so". Knee instability was defined as the occurrence of either symptom. Incident instability was defined as someone who answered "no" to experiencing either symptom at the 60 month visit but answered "yes" to one or both at the 72 or 84 month visit. Worsening of instability was defined as an increase in frequency using the 3-level variable with 0-1 times, 2-5 times, and >5 episodes over 3 months. Subjects with >5 times instability at 60 M were excluded. An increase in one level or more of frequency was considered worsening. A person-based analyses using Poisson regression with robust error variance to estimate adjusted relative risk for the association of VPT and muscle strength with knee instability incidence and progression was performed. We adjusted in analyses for age, sex, BMI, race, clinic site, KL grade and WOMAC knee pain as well as for each predictor (muscle strength and VPT).
Results: We evaluated 2212 participants (60% women, mean [SD] age ¼ 68 [8] years, and mean [SD] BMI ¼ 31 [6] ). 17% of participants reported buckling, 29% reported slipping and 37% reported instability (buckling and/or slipping) in the past 3 months at the 60-month visit. Over the follow-up period, 32% developed incident instability, and 20% had incident buckling. Similarly, 11% had worsening of instability, and 21% had worsening of buckling. Quadriceps weakness and impaired vibratory sense were each associated with the risk of incident knee instability, and impaired vibratory sense predicted worsening of both outcomes (see Table) . Conclusions: While arthroplasty patients with knee OA are marked by differences in demographic profile compared to those with hip OA, the results of the present study demonstrate that these variations alone fail to explain observed discrepancies in the prevalence of associated patient comorbidities. Even when controlled for demographic profile, smoking, and chronic steroid use, patients with knee OA continued to have significantly greater odds of an associated diagnosis of hypertension, diabetes, or the presence of metabolic syndrome. These findings further support the notion that knee OA is marked by unique associations with systemic disease. Further work is needed to better understand the nature of these associations, as well as to investigate potential interactions between these conditions, each of which has been reported to be independently associated with a systemic inflammatory state. Purpose: Functional limitations from hand, hip and knee osteoarthritis (OA) may impact the ability of diabetes patients to manage their diabetes. Thus, we examined the impact of OA symptom severity on diabetes-related complications in persons affected by both OA and diabetes. Methods: This retrospective cohort study used data from a population cohort with symptomatic hip and knee OA that was recruited from 1996-98 through a screening survey of 100% of the population aged 55þ years in two Ontario regions (n ¼ 2,225 had OA confirmed on examination and x-ray). The baseline survey assessed: socio-demographics; smoking; self-reported height, weight and NSAID use; comorbidity (including physician diagnosis and treatment in the past year for high blood pressure, diabetes, and heart problems); and mental health status (SF-36 mental health subscale). OA functional limitations were assessed using the Western Ontario McMaster Universities OA Index, WOMAC, physical function subscale, and the Health Assessment Questionnaire grip subscale and walking subscale (both 0-3; higher 
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